 |
|
|
|
 |
|
|
| Article 1 to 10 out of 15 concerning PerkinElmer, Inc.
|
-
Dr. Alan Fletcher Joins PerkinElmer as Vice President of Bio-Discovery Business Development
(16 Jul 2008)
PerkinElmer, Inc. announced that Alan Fletcher, Ph.D., has joined the Company as vice president, business development for PerkinElmer's Life and Analytical Sciences business. In this role, Fletcher will be responsible for growing the Bio-discovery ...
-
PerkinElmer Acquires Spectral Genomics, Inc.
(03 May 2006)
Molecular Karyotyping Technology Expected to Drive Advances in Prenatal and Neonatal Research and Disease Detection
PerkinElmer, Inc. announced the acquisition of the assets of Spectral Genomics, Inc., a company focussing on molecular karyotyping technology used to evaluate chromosomal abnormalities. Terms of the deal were not disclosed.Spectral Genomics' array ...
-
PerkinElmer and George Mason University Announce Alliance to Develop Novel Proteomic Technologies
(30 Mar 2006)
Biomarker Identification for Early Cancer Detection
PerkinElmer, Inc. announced a five-year research collaboration agreement with George Mason University to develop a new and innovative approach for cancer detection and risk stratification. Scientists from both organizations will work together on the ...
-
PerkinElmer and Jacobi Medical Center Establish Research Collaboration to Develop Molecular Diagnostics Screening Platforms
(27 Mar 2006)
PerkinElmer, Inc. announced a research collaboration agreement with Jacobi Medical Center, which is currently developing a centralized molecular genetics diagnostic laboratory that will ultimately serve the Health and Hospitals Corporation (HHC) of ...
-
PerkinElmer and University of Copenhagen Announce Licensing Agreement for New Maternal Health Marker ADAM12
(13 May 2005)
PerkinElmer Inc. has entered into a global licensing agreement with the University of Copenhagen in Copenhagen, Denmark, to develop assay kits for the biochemical marker ADAM12. ADAM12 has broad potential in maternal health screening as a marker for ...
-
PerkinElmer and Nonlinear Dynamics Expand Agreement to Provide Comprehensive Proteomics Solutions
(26 Apr 2005)
PerkinElmer, Inc. and Nonlinear Dynamics Ltd. (NLD), a provider of proteomics image analysis software and bioinformatics tools, announced the signing of an expanded partnership agreement to develop and market application-driven proteomics solutions. ...
-
PerkinElmer and Predictive Diagnostics announce Discovery of Blood Biomarkers for Alzheimer's Disease
(22 Apr 2005)
PerkinElmer Inc. and Predictive Diagnostics, Inc., a wholly owned subsidiary of Large Scale Biology Corporation, announced that they have found a series of biomarkers that appear to differ in persons with Alzheimer's Disease compared to persons ...
-
PerkinElmer and Procognia to offer breakthrough protein array platform
(01 Feb 2005)
PerkinElmer, Inc. and Procognia, a leading developer of innovative and transformational technologies in the field of proteomics, announced an exclusive distribution and co-marketing agreement to deliver the only complete solution for high-throughput ...
-
PerkinElmer and Procognia to Offer Breakthrough Protein Array Platform
(17 Dec 2004)
PerkinElmer, Inc. and Procognia announced an exclusive distribution and co-marketing agreement to deliver the only complete solution for high-throughput and high-resolution analysis of the glycosylation of proteins. Procognia's U-c fingerprint ...
-
PerkinElmer Announces Agreement with Predictive Diagnostics That Allows for Comprehensive Biomarker Platform
(14 Sep 2004)
New Biomarker Platform Critical In Accelerating Drug Development
PerkinElmer Inc. andPredictive Diagnostics, Inc. (PDI) announced they have entered into a collaborative partnership for advanced biomarker discovery technology to accelerate drug development and diagnostic testing.Under the terms of the agreement, ...
|
|
|
|
|
Top
